Ron Bentsur - 04 Feb 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
04 Feb 2022
Net transactions value
+$1,153,145
Form type
4
Filing time
08 Feb 2022, 12:13:59 UTC
Previous filing
26 Nov 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock, par value $0.00001 Purchase $1,000,000 +200,000 +7.8% $5.00 2,765,459 04 Feb 2022 Direct F1, F2
transaction NVCT Common Stock, par value $0.00001 Purchase $48,625 +12,500 +0.45% $3.89 2,777,959 04 Feb 2022 Direct F2, F3
transaction NVCT Common Stock, par value $0.00001 Purchase $55,020 +14,000 +0.5% $3.93 2,791,959 07 Feb 2022 Direct F2, F4
transaction NVCT Common Stock, par value $0.00001 Purchase $49,500 +6,000 +0.21% $8.25 2,797,959 07 Feb 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the price of shares of common stock purchased by Mr. Bentsur in Nuvectis Pharma's initial public offering.
F2 Includes 96,759 shares of restricted stock.
F3 Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.83 to $3.95. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F4 Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.60 to $4.25. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.